501 related articles for article (PubMed ID: 10085006)
1. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
[TBL] [Abstract][Full Text] [Related]
2. Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae.
Ryan ET; Crean TI; Kochi SK; John M; Luciano AA; Killeen KP; Klose KE; Calderwood SB
Infect Immun; 2000 Jan; 68(1):221-6. PubMed ID: 10603391
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains.
Butterton JR; Ryan ET; Acheson DW; Calderwood SB
Infect Immun; 1997 Jun; 65(6):2127-35. PubMed ID: 9169742
[TBL] [Abstract][Full Text] [Related]
5. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
6. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.
de Haan L; Verweij W; Agsteribbe E; Wilschut J
Immunol Cell Biol; 1998 Jun; 76(3):270-9. PubMed ID: 9682971
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae.
John M; Crean TI; Calderwood SB; Ryan ET
Infect Immun; 2000 Mar; 68(3):1171-5. PubMed ID: 10678922
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.
Gerber S; Lane C; Brown DM; Lord E; DiLorenzo M; Clements JD; Rybicki E; Williamson AL; Rose RC
J Virol; 2001 May; 75(10):4752-60. PubMed ID: 11312347
[TBL] [Abstract][Full Text] [Related]
10. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain.
Ryan ET; Butterton JR; Smith RN; Carroll PA; Crean TI; Calderwood SB
Infect Immun; 1997 Jul; 65(7):2941-9. PubMed ID: 9199470
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.
Norton EB; Lawson LB; Freytag LC; Clements JD
Clin Vaccine Immunol; 2011 Apr; 18(4):546-51. PubMed ID: 21288994
[TBL] [Abstract][Full Text] [Related]
12. Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat-labile enterotoxin subunit B.
Schödel F; Will H; Johansson S; Sanchez J; Holmgren J
Gene; 1991 Mar; 99(2):255-9. PubMed ID: 2022336
[TBL] [Abstract][Full Text] [Related]
13. Immunization with a Double-Mutant (R192G/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model.
Albert MJ; Haridas S; Ebenezer M; Raghupathy R; Khan I
PLoS One; 2015; 10(11):e0142090. PubMed ID: 26540197
[TBL] [Abstract][Full Text] [Related]
14. Heterologous antigen expression in Vibrio cholerae vector strains.
Butterton JR; Beattie DT; Gardel CL; Carroll PA; Hyman T; Killeen KP; Mekalanos JJ; Calderwood SB
Infect Immun; 1995 Jul; 63(7):2689-96. PubMed ID: 7790086
[TBL] [Abstract][Full Text] [Related]
15. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.
O'Neal CM; Clements JD; Estes MK; Conner ME
J Virol; 1998 Apr; 72(4):3390-3. PubMed ID: 9525668
[TBL] [Abstract][Full Text] [Related]
16. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.
Mason HS; Haq TA; Clements JD; Arntzen CJ
Vaccine; 1998 Aug; 16(13):1336-43. PubMed ID: 9682399
[TBL] [Abstract][Full Text] [Related]
17. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins.
Jagusztyn-Krynicka EK; Clark-Curtiss JE; Curtiss R
Infect Immun; 1993 Mar; 61(3):1004-15. PubMed ID: 8432584
[TBL] [Abstract][Full Text] [Related]
19. Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine.
Lu X; Clements JD; Katz JM
Vaccine; 2002 Jan; 20(7-8):1019-29. PubMed ID: 11803061
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain.
Guillobel HC; Carinhanha JI; Cárdenas L; Clements JD; de Almeida DF; Ferreira LC
Infect Immun; 2000 Jul; 68(7):4349-53. PubMed ID: 10858258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
